AzTrials
AzTrials

Post-operative Pain, AcuteNCT05242328

Postoperative Analgesia y After Uniportal Video-assisted Thoracoscopic Surgery

A study testing Ultrasound-guided erector spinae plane block and surgical thoracoscopic intercostal nerve block in people with Post-operative Pain, Acute and Post-operative Pain, run by National Cheng-Kung University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Ultrasound-guided erector spinae plane block (ESPB) is an interfascial blockade during thoracic anesthesia, first described by Forero in 2016, and is highlighted by technically feasibility and less complication rate. The patient is placed as decubitus position. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Ultrasound-guided erector spinae plane block and surgical thoracoscopic intercostal nerve block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTaiwan
Study dates
5 Jan 2021to 26 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult patients, over 20 years old, u
  • undergoing elective uniportal VATS lobectomy.

Who cannot join

  • patient refusal,
  • body mass index > 35 kg/m2,
  • American society of anesthesiologists (ASA) grade above 3,
  • contraindication to nerve block,
  • allergy to analgesic agents,
  • regular opioid used for chronic pain prior to this time surgery,
Show all 9Show fewer
  • conversion to thoracotomy or VATS procedure,
  • postoperative intubation,
  • postoperative intensive care unit admission.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site, 1 recruiting
  • National Cheng Kung University Hospital

    Tainan

    Shuoying Dai, MD, +886-6-2353535 ext. 5182, hsnu_10@yahoo.com.te

    Recruiting

Other trials in Taiwan

About this study

Official title: Comparison of Surgical Thoracoscopic Intercostal Nerve Block and Ultrasound-guided Erector Spinae Plane Block for Postoperative Analgesia and Enhanced Recovery After Uniportal Video-assisted Thoracoscopic Surgery: a Double-blinded, Randomized Controlled Trial

Ultrasound-guided erector spinae plane block (ESPB) is an interfascial blockade during thoracic anesthesia, first described by Forero in 2016, and is highlighted by technically feasibility and less complication rate. The patient is placed as decubitus position. The anesthesiologists use echo to identify the ipsilateral transverse process at T5 level, and insert the needle to 2-3 cm lateral to the spinous process until contact the transverse process. Then the injected local anesthetic will penetrate via erector spinae muscle to paravertebral space to affect and relieve pain.

Being tested
Ultrasound-guided erector spinae plane block, surgical thoracoscopic intercostal nerve block
Keywords
Uniportal video-assisted thoracoscopic surgery, Ultrasound-guided erector spinae plane block, surgical thoracoscopic intercostal nerve block, cumulative intravenous morphine consumption, visual analogue scale, Enhanced Recovery After Surgery
Medical subject headings
Pain, Postoperative, Thoracic Diseases, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound-guided erector spinae plane blockProcedure or surgery

    Ultrasound-guided erector spinae plane block

  • surgical thoracoscopic intercostal nerve blockProcedure or surgery

    surgical thoracoscopic intercostal nerve block

Study groups in NCT05242328
Study groupRoleWhat they receive
post-operative VAS score of Ultrasound-guided erector spinae plane blockActive comparatorNot described
Receives: Procedure: Ultrasound-guided erector spinae plane block
post-operative VAS score of surgical thoracoscopic intercostal nerve blockActive comparatorNot described
Receives: Procedure: surgical thoracoscopic intercostal nerve block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analogue scale

    post-op VAS score, 0-10, the higher means painful, and "0" point no pain.

    Measured: post-op 2 days

  2. accumulated morphine usage dose

    accumulated morphine usage dose

    Measured: post-op 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2022
  2. Study start5 Jan 2021
  3. Primary completion26 Dec 2024 (estimated)
  4. Study completion26 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05242328
Sponsor's protocol ID
A-ER-110-293
Status last verified
Dec 2022
First submitted
26 Jan 2022
Last updated
27 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound-guided erector spinae plane block and surgical thoracoscopic intercostal nerve block in people with Post-operative Pain, Acute and Post-operative Pain, run by National Cheng-Kung University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shuoying Dai, MD (+886-6-2353535 ext. 5182, hsnu_10@yahoo.com.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analogue scale (time frame: post-op 2 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in